Skip to search formSkip to main contentSkip to account menu

AD 5

Known as: AD-5 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AlanineN-(4-methoxyphenylacetyl)dehydroalanine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression
Correction to: Cancer Gene Therapy (2012) 19, 336–344; doi: 10.1038/cgt.2012.6 Information regarding an additional funding agency… 
2011
2011
A phase I trial of VB-111, a tissue- and condition-specific dual action vascular disruptive and antiangiogenic agent, for treatment of patients with advanced metastatic cancer.
3038 Background: VB-111 is a tissue and condition specific vascular disrupting and anti-angiogenic agent based on a novel… 
2010
2010
Abstract 1361: A Phase I trial of VB-111, a tissue and condition specific vascular disruptive anti-angiogenic agent, based on novel Vascular Targeting System™, VTS™, for treatment of patients with…
Introduction: VB-111 is a vascular disruptive and anti-angiogenic agent consisting of a non-replicating adenovirus vector (Ad-5… 
1994
1994
Suppressed phagocytosis but promoted bacterial growth upon the effect of virus free supernatants of infected lymphocytes.
The pathomechanism of suppressed phagocytosis and bacterial superinfections which follow viral diseases is not completely… 
1986
1986
29a-AD-5 量子スピン系のモンテカルロ法(統計力学・物性基礎論)
1978
1978
3p-AD-5 PP→Δ,Λ^-,Σ^±(1385)+anything at 400GeV/c
1978
1978
1a-AD-5 EuB_6のESR
1975
1975
Ultrastructural changes in cellular components in WI cells inoculated with adenovirus type 5.
A detailed analysis by means of electron microscopy of the cells inoculated with Ad-5 was reported and showed the presence of… 
1959
1959
Dynamic visual acuity in an applied setting.
Abstract : A Navy AD-5 (attack bomber) was used to fly subjects over targets (Landolt C's) at angular velocities decelerating… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)